BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MT-201 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MT-201\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07113522-47@assetmemo.bio
DTSTAMP:20261121T004016Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:MT-201: Phase 2 readout est. (NCT07113522)
DESCRIPTION:MT-201\, phase 2\, Ulcerative Colitis.\nStudy: A Phase 2 Study 
 to Evaluate Therapies for Inflammatory Bowel Disease\nEstimated primary co
 mpletion: 30 April 2027. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/mt-201#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT07113522
URL:https://assetmemo.bio/drug/mt-201#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
